Ascensia Diabetes Care
Switzerland · www.ascensia.com · 12 vendors
Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes. They provide blood glucose monitoring systems, including the CONTOUR® portfolio, and other diabetes management solutions to help individuals manage their condition.
Resilience scores
- Digital Sovereignty: 0
- Digital Resilience: 7
Technology vendors
- Adobe Inc. — Technology — United States
- Demandware — Technology — United States
- Meta Platforms, Inc. — Technology — United States
- and 9 more
Services catalogue
1 service in catalogue across 1 category; runs on 12 sub-vendors.
- Blood Glucose Monitoring
Insights
Last updated 2026-07-30 · revision 1
12 direct vendors, 225 subvendors
Direct vendors by controlling owner country (sample)
- United States: 10
- Bulgaria: 1
- Denmark: 1
Subvendors by controlling owner country (sample)
- Czech Republic: 1
- Belgium: 1
- Luxembourg: 1
Migration Readiness: 5/10
Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.
Ascensia Diabetes Care exhibits a medium level of migration readiness, scoring 45. The company's focus on mobile health applications, diabetes data management platforms, and extensive digital health interoperability (180+ BGM data integration partners) suggests an inherent need for scalable, flexible, and potentially cloud-based infrastructure, which presents an opportunity for successful migration. The internal tech stack includes modern mobile development capabilities (iOS/Android with Swift/Objective-C, Kotlin/Java), indicating a workforce capable of adapting to contemporary cloud-native development practices. However, significant challenges and unknowns temper its readiness. Crucially, there is no information regarding the regulatory environment or specific data residency requirements, which are paramount and often complex in the healthcare industry and can heavily influence migration strategies. The financial stability to fund a potentially large-scale migration is also not provided. While the company uses modern mobile technologies, there is no explicit mention of cloud-native architectures, containerization, or microservices for its backend data management platforms. The use of Episerver (Optimizely) CMS, while capable of cloud deployment, may require substantial refactoring for a full cloud-native migration. The vendor landscape is also a concern; while 19 services are listed with vendor HQs in 3 countries, the "Total Vendors: 0" entry is ambiguous, making it difficult to ascertain the actual number of distinct vendors and the extent of potential vendor lock-in. The explicit vendor lock-in risk is unknown, and deep product partnerships (e.g., with Medtronic for CONTOUR™NEXT LINK and Senseonics for Eversense CGM) could introduce complex integration dependencies that would need careful management during any migration process.
Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.